126 filings
Page 3 of 7
8-K
pwu3863 aybg8814
8 Jul 21
Accolade Announces Results for Fiscal First Quarter 2022
4:07pm
DEF 14A
2pqn79yj34ao60 kzbs
25 Jun 21
Definitive proxy
4:27pm
D
f1ebjq7
21 Jun 21
$390.36M in equity, sold $325.28M, 79 investors
11:28am
8-K
ngwv9k7zesy dhbu
10 Jun 21
Entry into a Material Definitive Agreement
4:59pm
S-8
aguxpk8d5749
9 Jun 21
Registration of securities for employees
10:00pm
8-K
vkll8coao7
7 Jun 21
Departure of Directors or Certain Officers
4:50pm
8-K
rh6 0t3jgys3w1lm62
1 Jun 21
Entry into a Material Definitive Agreement
5:02pm
EFFECT
w1m3rq jk0
20 May 21
Notice of effectiveness
12:15am
POS AM
j03w9ebwxd9 k2lw86
11 May 21
Prospectus update (post-effective amendment)
12:00am
10-K
ym1tyyffd
7 May 21
Annual report
5:06pm
8-K/A
zh906hbero2t yxi36
6 May 21
CORRECTION -- Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2021
12:00am
8-K
anzlb gqm
5 May 21
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2021
4:08pm
8-K
b8uo5it hs
23 Apr 21
Accolade to Acquire PlushCare
5:13pm
424B3
i352ezj9sxsd0ds m5
6 Apr 21
Prospectus supplement
6:06am
EFFECT
1zes49lmlzpno0ml
6 Apr 21
Notice of effectiveness
12:16am
CORRESP
niceu3tc1n
1 Apr 21
Correspondence with SEC
12:00am
8-K
hrbqix of
29 Mar 21
Accolade Announces Private Offering of $250 Million Convertible Notes
5:29pm
8-K
co0w0
23 Mar 21
Accolade Announces Private Offering of $250 Million Convertible Notes
5:08pm